Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.
about
Calmodulin-kinases: modulators of neuronal development and plasticityFragile X syndrome: loss of local mRNA regulation alters synaptic development and functionGroup 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and diseaseAdvances in the treatment of fragile X syndromeTemporal requirements of the fragile X mental retardation protein in the regulation of synaptic structuremTOR signaling: at the crossroads of plasticity, memory and diseaseA new look at an old drug: neuroprotective effects and therapeutic potentials of lithium saltsClinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders.Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of AutismFragile X syndrome and targeted treatment trials.Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us.The pathophysiology of fragile X (and what it teaches us about synapses)Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.Haploinsufficiency of Cyfip1 produces fragile X-like phenotypes in miceTherapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and BackFragile X mental retardation protein: A paradigm for translational control by RNA-binding proteinsSynaptic plasticity: multiple forms, functions, and mechanismsFMR1 transcript isoforms: association with polyribosomes; regional and developmental expression in mouse brainBidirectional regulation of synaptic transmission by BRAG1/IQSEC2 and its requirement in long-term depressionElongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTDThe FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuitsPhosphorylation of FMRP and alterations of FMRP complex underlie enhanced mLTD in adult rats triggered by early life seizures.Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptorsSelective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.Behavioral changes following a single episode of early-life seizures support the latent development of an autistic phenotype.Stem cells and modeling of autism spectrum disorders.Modeling fragile X syndrome in the Fmr1 knockout mouseRas signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome.Fragile X syndrome: mechanistic insights and therapeutic avenues regarding the role of potassium channels.Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders.A mouse model of the human Fragile X syndrome I304N mutation.BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability.Lithium: a promising treatment for fragile X syndrome.Necessary, but not sufficient: insights into the mechanisms of mGluR mediated long-term depression from a rat model of early life seizuresMeeting at the crossroads: common mechanisms in Fragile X and Down syndromeDysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and AutismmGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learningGenetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model.Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndromeAltered mRNA transport, docking, and protein translation in neurons lacking fragile X mental retardation protein
P2860
Q24315924-7688350F-5481-4AD6-8181-C9E5BE532F37Q24608468-690A3274-B31E-4CF7-BA3A-84A21EAE9EAAQ24620534-D8B090F5-2672-4553-B3E3-235A40225726Q24632814-7E2D9D73-2F54-4AC5-8E2F-80CBAFE212F6Q24645505-F42C8278-62E3-43A7-85B5-4272E6DA48BEQ24647655-E236E9D2-2681-4602-A85B-2C87A35FD934Q26741164-F7DE22CD-E007-45B8-BABC-CFAA14E7C25AQ26748761-F7B5AD4F-34CA-44D3-8616-5473AB389500Q26782948-57D47D6C-BE22-4615-B46C-202C8E6F8985Q26865162-0D32DD85-2662-42EB-A5ED-5A1DB2A48BACQ26866506-EBB9A1A8-A4F8-4161-89FF-838A742A94EDQ27010675-6307F024-9231-4DB8-9943-B6EC9FF05054Q27301086-2AB085B1-3716-47AA-AD6B-E3D1D268472DQ27325468-1CC6F0C5-B4C4-4FC2-A0FC-A5625199CC9CQ27337360-96103C7E-D165-4803-A37F-3E8C4877FCD1Q28086823-583BDA34-52ED-46C2-86E4-0F8B3567720EQ28242702-4C285D4A-C5B8-4737-B278-17B71E16845BQ28487767-90084040-3936-416E-93C9-A167F094003FQ28571020-E5F02EDD-4D98-4ED7-9EEF-E8FF02C12212Q28585633-74487695-8404-4F33-BA6B-3484D058D0E1Q28588310-06A4E265-18E2-4176-83DE-55BA5D339B91Q28771396-33DD5F15-1106-4671-8081-E78C491821F7Q28771397-D1E7F38D-E40F-4733-A66B-028E34548EF1Q30376422-33AD55F3-C38D-4223-B682-6F77344DFD92Q30389603-DC808D8D-6BDC-4C9D-9CE3-08D384001F86Q30401824-9682E572-52A0-4FFD-AA11-94CC66F26A09Q30420595-93894147-C0B5-4036-AB62-E8840551E73DQ30441120-BC98B13C-F660-4868-B3AA-F90B8D30095BQ30448604-8E25793F-E745-4AAF-B625-28B80D8E04B8Q30469044-2A9E565F-FA96-41C0-B19A-18E4923EF709Q30484632-2FF6B441-C115-48EF-8AF8-17C02DDA4E96Q30494390-174117FF-57DA-4E1E-B432-F6672CF5E803Q33777951-D07A076A-A3E0-44B2-B843-9FBC14BB5765Q33864150-1FCC1EB9-BA75-407F-A7FB-956C65E3519BQ33874584-A1410711-F15B-494E-BCA6-793D8F5B044DQ33877423-AD830A3B-2E39-4A6C-A53F-15F3FA431C10Q33908562-15F7E424-4025-413E-830F-A0000438F928Q33935973-8F0EDFC4-B415-4289-96D4-81EBC2FEF572Q33953276-A559487B-7062-45CF-8219-3B5EF861943DQ34100256-58905163-7C01-4E14-BF55-9F71C9F62FEE
P2860
Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Metabotropic receptor-dependen ...... e model of fragile X syndrome.
@en
Metabotropic receptor-dependen ...... e model of fragile X syndrome.
@nl
type
label
Metabotropic receptor-dependen ...... e model of fragile X syndrome.
@en
Metabotropic receptor-dependen ...... e model of fragile X syndrome.
@nl
prefLabel
Metabotropic receptor-dependen ...... e model of fragile X syndrome.
@en
Metabotropic receptor-dependen ...... e model of fragile X syndrome.
@nl
P2860
P356
P1476
Metabotropic receptor-dependen ...... e model of fragile X syndrome.
@en
P2093
Elena D Nosyreva
Kimberly M Huber
P2860
P304
P356
10.1152/JN.01316.2005
P407
P577
2006-02-01T00:00:00Z